Complete vs Culprit-Only Revascularization in Older Patients With MI and High Bleeding Risk

Andrea Erriquez,Gianluca Campo,Vincenzo Guiducci,Javier Escaned,Raul Moreno,Gianni Casella,Mila Menozzi,Enrico Cerrato,Giorgio Sacchetta,Alberto Menozzi,Ignacio Amat Santos,Enrique Gutiérrez Ibañes,Roberto Scarsini,Giuseppe Vadalà,Giuseppe Andò,José Luis Díez-Gil,Sergio Musto d’Amore,Alessandro Capecchi,Iginio Colaiori,Francesco Gallo,Rita Pavasini,Andrea Marrone,Graziella Pompei,Valerio Lanzilotti,Dariusz Dudek,Emanuele Barbato,Matteo Tebaldi,Simone Biscaglia
DOI: https://doi.org/10.1001/jamacardio.2024.0804
2024-06-13
JAMA Cardiology
Abstract:This randomized clinical trial investigates if patients with high bleeding risk and a history of myocardial infarction (MI) would benefit from complete vs culprit-only revascularization.
cardiac & cardiovascular systems
What problem does this paper attempt to address?